Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

Released
2025-07-16 19:25
  • health news
  • news
  • web article

Read more on www.cnbc.com

Picture from image.cnbcfm.com

Related items

Published by

CNBC

In one list